Does AMBRISENTAN Cause Pulmonary hypertension? 1,504 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,504 reports of Pulmonary hypertension have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 1.7% of all adverse event reports for AMBRISENTAN.
1,504
Reports of Pulmonary hypertension with AMBRISENTAN
1.7%
of all AMBRISENTAN reports
404
Deaths
940
Hospitalizations
How Dangerous Is Pulmonary hypertension From AMBRISENTAN?
Of the 1,504 reports, 404 (26.9%) resulted in death, 940 (62.5%) required hospitalization, and 35 (2.3%) were considered life-threatening.
Is Pulmonary hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 1,504 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Pulmonary hypertension?
TREPROSTINIL (1,931)
MACITENTAN (1,505)
SELEXIPAG (681)
EPOPROSTENOL (591)
SILDENAFIL (517)
BOSENTAN (504)
TADALAFIL (428)
RIOCIGUAT (411)
ADALIMUMAB (287)
DASATINIB (249)
Which AMBRISENTAN Alternatives Have Lower Pulmonary hypertension Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE